Home › Neurologic Diseases › Texas › San Antonio
Neurologic Diseases clinical trials in San Antonio, TX
4 studies for Neurologic Diseases are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
RecruitingPhase 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- The University of Texas Health Science Center, San Antonio
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- San Antonio, Texas, San Antonio
Product Surveillance Registry
RecruitingObservational study
- San Antonio, San Antonio
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Orlando, FL7 studies
- Miami, FL7 studies
- Washington, DC7 studies
- Philadelphia, PA7 studies
- Dallas, TX7 studies
- Houston, TX7 studies
- San Diego, CA6 studies
- St. Louis, MO6 studies
- Austin, TX5 studies
- New York City, NY5 studies
- Los Angeles, CA5 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer45 studies
- Metastatic Cancer44 studies
- Colorectal Cancer43 studies
- Cancer (all types)41 studies
- Obesity39 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer33 studies
- Pancreatic Cancer33 studies
- Lung Cancer27 studies
- Prostate Cancer27 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.